DNA

Ginkgo Bioworks Holdings Inc

9.22

-0.47-4.85%

After Hours: 9.23 +0.01 +0.11%19:43 02/20 EST

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE9.55/9.69

TODAY RANGE9.14-9.65

VOL642.35K

MARKET CAP558.64M

52 WEEK RANGE5.00-17.58

AVG VOL (3M)1.01M

% TURNOVER1.06%

TURNOVER--

P/E (TTM)-1.4812

% RANGE5.26%

EPS(TTM)-6.2246

P/E(FORWARD)-1.6333

P/B0.9361

BVPS9.85

DIVIDEND--

P/S2.208

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP537.50M

SHARES OUTSTANDING60.59M

NEXT EARNINGS02/25-03/03

FREE FLOAT58.30M

LOT SIZE1

EX-DATE08/20/2024

News

Press Releases

Financial Reports

Profile

PR Newswire·2d ago
Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation
TipRanks·3d ago
Ginkgo Bioworks, Invaio Sciences enter collaboration
Seeking Alpha·02/12 13:00
AI Beyond The Chatbot: The New Value Chain
Simply Wall St·02/08 12:16
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) institutional owners may be pleased with recent gains after 29% loss over the past year
Benzinga·02/06 17:05
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga·02/06 09:54
Why Roblox Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
Seeking Alpha·02/05 19:44
Ginkgo - OpenAI collaboration cuts costs in protein synthesis
TipRanks·02/05 19:21
OpenAI says worked with Ginkgo on autonomous lab
TipRanks·02/05 19:15
Ginkgo Bioworks jumps after OpenAI comment on working together
Benzinga·02/05 19:10
Ginkgo Bioworks Demonstrates, In Collaboration With OpenAI, An AI System That Autonomously Designed, Executed, And Learned From Biological Experiments With Minimal Human Involvement; Co. Reports The System Reduced Cell-Free Protein Synthesis Reaction Costs By 40% Relative To State Of The Art; GPT-5-Driven Autonomous Lab Executed Over 36,000 Experiments
PR Newswire·02/05 19:00
Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark
NASDAQ·01/14 23:15
Ginkgo Bioworks Holdings, Inc. (DNA) Increases Despite Market Slip: Here's What You Need to Know
PR Newswire·01/13 13:00
Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
TipRanks·01/09 16:15
Private Markets: Anthropic raising $10B at $350B valuation
Dow Jones·01/08 18:52
Ginkgo Bioworks Holdings Price Target Cut to $12.00/Share From $14.00 by TD Cowen

Same Industry

Name/Symbol

Change%

Price

Ginkgo Bioworks Holdings Inc

DNA

-4.85%

9.22

Regeneron Pharmaceuticals

REGN

-0.23%

779.67

GridAI Tech

GRDX

-5.15%

2.58

BIONTECH

BNTX

-0.25%

110.15

United Therapeutics Corp.

UTHR

-1.48%

473.42

Vertex Pharmaceuticals Inc

VRTX

+1.63%

476.90

Siga Technologie

SIGA

-0.30%

6.75

Moderna

MRNA

+0.34%

49.87

Charles Riv Labs Intl Inc

CRL

+2.85%

168.92

Medpace Holdings

MEDP

+1.64%

453.77

Talphera Inc

TLPH

-3.87%

0.7766

China Biologic

CBPO

119.99

ICON PLC

ICLR

+1.31%

99.70

Iqvia Hldgs Inc

IQV

-2.21%

165.62

MOLECULAR PARTNERS AG

MOLN

0.00%

5.00

Gilead Sciences Inc

GILD

+0.19%

151.40

PRA Health

PRAH

165.21

Arcturus Therape

ARCT

-3.76%

7.67

Incyte Corp

INCY

-0.40%

101.32

Aptevo Therapeutics Inc

APVO

-4.58%

6.66

Biospecifics

BSTC

+0.15%

88.53